surgical laparoscopy News
-
Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to partner with ...
-
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2021
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2021. Recent Highlights Record quarter for procedures performed using Senhance® Surgical Systems, growing 47% over the ...
-
Dexter Series E: $90M to Make Sense of Robotic Surgery
Distalmotion, Revival Healthcare Capital and 415 CAPITAL announce the closing of a USD 90 million Series E financing round to accelerate the adoption of Distalmotion’s surgical robot Dexter. The investment follows Dexter’s successful initial clinical use and supports Distalmotion’s international commercial scaling. More than capital: A partnership of medtech pioneers and ...
-
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 3, 2021
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 third quarter financial and operating results after the market closes on Wednesday, November 3, 2021. The Company will host a conference call to discuss ...
-
Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect 2022 Conference
Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company’s virtual presentation will take place on Thursday, January 13, 2022 at 9:00 am Eastern Time. In addition, ...
-
New View Surgical, Inc. Announces FDA Clearance of its VisionPort™ System for Minimally Invasive Surgery
New View Surgical, Inc., a medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for its VisionPort™ System. The VisionPort™ imaging and access system simplifies laparoscopic procedures for hospitals and provides surgeon-controlled ...
-
Lumendi Reports First Incisionless Appendectomy Using Double-Balloon Endolumenal Interventional Platform
Patient reported no post-procedure pain and resumed regular activity day after procedure Connecticut-based medical device innovator Lumendi, LLC reports the first endoscopic appendectomy using its DiLumenTM Endolumenal Interventional Platform (EIP). A patient underwent the purely endoscopic endolumenal appendectomy to remove a lesion previously identified at the appendiceal orifice. ...
By Lumendi Ltd.
-
Palisade Bio And Newsoara Receive NMPA Clearance To Commence Phase 3 Clinical Trial In China Evaluating LB1148 To Accelerate The Return Of Bowel Function Following Abdominal Surgery
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S. Food and Drug Administration to commence Phase 3 study Newsoara to fully fund Phase 3 program in China Under the Co-Development Agreement, commencement of Phase 3 program in China will trigger milestone payment to Palisade Bio Palisade Bio (Nasdaq: PALI), a clinical stage ...
By Palisade Bio
-
Plasma Surgical Announces Expanded Indications for Use for the PlasmaJet® Surgery System
FDA 510(k) clearance for removal of soft tissue by vaporization offers additional utility for surgeons ROSWELL, Ga. – May 1, 2013 – Plasma Surgical, creator of the PlasmaJet®, an advanced energy medical device designed as a safe and effective alternative to traditional electrosurgery instruments, announced today that it has received 510(k) clearance from the U.S. Food and Drug ...
-
Lumendi Receives 510(K) Clearance for Dilumen Ik Endolumenal Interventional Knife
Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the DiLumen Ik™ Endolumenal Interventional Knife, a sterile, single-use, disposable monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures. ...
By Lumendi Ltd.
-
Asensus Surgical Announces FDA Clearance in General Surgery
Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United ...
-
Asensus Surgical, Inc. Announces Hirosaki University Hospital to Initiate Senhance Robotic Surgery Program
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Hirosaki University Hospital has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to add a system at Hirosaki University Hospital ...
-
Asensus Surgical Announces Franklin Medical Center to Initiate the Installation of the Senhance Surgical System
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Franklin Medical Center in Winnsboro, Louisiana has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to bring the Senhance ...
-
Asensus Surgical Announces Purchase of Senhance Robotic System by RZD Medicine
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Private Healthcare Institution Railway Clinical Hospital RZD Medicine of Rostov-on-Don (“RZD Medicine”), located in Rostov, Russia, has initiated its Senhance® Robotic ...
-
Asensus Surgical, Inc. Announces Sapporo Medical University Hospital in Japan to Initiate Senhance Robotic Surgery Program
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System. “The Department of Surgery, ...
-
Asensus Surgical Announces Board Chair Transition
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Paul LaViolette, who has served as the Company’s Board Chair since 2013, will step down as Chair in late October, and intends to leave the Board before the end of the year. ...
-
Medical Microinstruments Participates in the “Minimally Invasive Robotic Surgery Systems (TREMIRS)” Project
PISA, Italy. June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). REFERENCE: CPI-2019-33-1-TRE-14. in the framework of the Line for the Promotion of Innovation from the Demand for the Public ...
-
Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. Fourth Quarter Highlights Over 500 procedures were performed globally during the quarter, representing growth of over 25% over the ...
-
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2020
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the fourth quarter and full-year 2020. Recent Highlights Senhance Surgical System received expanded 510(k) clearance for general ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you